Publisher: Wiley-Blackwell on behalf of the International Society on Thrombosis and Haemostasis

Related content
Volume 9, Number 12, 1 December 2011

< previous issue | all issues | next issue >

Favourites:Add to Favourites

Free Content Sex differences in the relationship between inflammatory and hemostatic biomarkers and metabolic syndrome: British 1958 Birth Cohort
pp. 2337-2344(8)
Authors: RUDNICKA, A. R.; RUMLEY, A.; WHINCUP, P. H.; LOWE, G. D.; STRACHAN, D. P.

Favourites:Add to Favourites

Free Content Intracardiac expression of markers of endothelial damage/dysfunction, inflammation, thrombosis, and tissue remodeling, and the development of postoperative atrial fibrillation
pp. 2345-2352(8)
Authors: KAIREVICIUTE, D.; LIP, G. Y. H.; BALAKRISHNAN, B.; UZDAVINYS, G.; NORKUNAS, G.; KALINAUSKAS, G.; SIRVYDIS, V.; AIDIETIS, A.; ZANETTO, U.; SIHOTA, H.; MAHESHWARI, M.; BLANN, A. D.

Favourites:Add to Favourites

Free Content Incidence of thrombotic and bleeding complications during cardiac catheterization in children: comparison of high‐dose vs. low‐dose heparin protocols
pp. 2353-2360(8)
Authors: HANSLIK, A.; KITZMÜLLER, E.; THOM, K.; HAUMER, M.; MLEKUSCH, W.; SALZER‐MUHAR, U.; MICHEL‐BEHNKE, I.; MALE, C.

Favourites:Add to Favourites

Free Content Early glycoprotein IIb‐IIIa inhibitors in primary angioplasty‐abciximab long‐term results (EGYPT‐ALT) cooperation: individual patient’s data meta‐analysis
pp. 2361-2370(10)
Authors: DE LUCA, G.; BELLANDI, F.; HUBER, K.; NOC, M.; PETRONIO, A. S.; ARNTZ, H. ‐R.; MAIOLI, M.; GABRIEL, H. M.; ZORMAN, S.; DE CARLO, M.; RAKOWSKI, T.; GYONGYOSI, M.; DUDEK, D.

Favourites:Add to Favourites

Free Content Influence of high‐density lipoprotein and paraoxonase‐1 on platelet reactivity in patients with acute coronary syndromes receiving clopidogrel therapy
pp. 2371-2378(8)
Authors: TSELEPIS, A. D.; TSOUMANI, M. E.; KALANTZI, K. I.; DIMITRIOU, A. A.; TELLIS, C. C.; GOUDEVENOS, I. A.

Favourites:Add to Favourites

Free Content Antiplatelet effects of prasugrel vs. double clopidogrel in patients on hemodialysis and with high on‐treatment platelet reactivity
pp. 2379-2385(7)
Authors: ALEXOPOULOS, D.; PANAGIOTOU, A.; XANTHOPOULOU, I.; KOMNINAKIS, D.; KASSIMIS, G.; DAVLOUROS, P.; FOURTOUNAS, C.; GOUMENOS, D.

Favourites:Add to Favourites

Free Content Immunogenic but effective: the HIT‐fondaparinux brain puzzler
pp. 2386-2388(3)
Author: GREINACHER, A.

Favourites:Add to Favourites

Free Content Fondaparinux treatment of acute heparin‐induced thrombocytopenia confirmed by the serotonin‐release assay: a 30‐month, 16‐patient case series
pp. 2389-2396(8)
Authors: WARKENTIN, T. E.; PAI, M.; SHEPPARD, J. I.; SCHULMAN, S.; SPYROPOULOS, A. C.; EIKELBOOM, J. W.

Favourites:Add to Favourites

Free Content Economic burden and cost determinants of deep vein thrombosis during 2 years following diagnosis: a prospective evaluation
pp. 2397-2405(9)
Authors: GUANELLA, R.; DUCRUET, T.; JOHRI, M.; MIRON, M.‐J.; ROUSSIN, A.; DESMARAIS, S.; JOYAL, F.; KASSIS, J.; SOLYMOSS, S.; GINSBERG, J. S.; LAMPING, D. L.; SHRIER, I.; KAHN, S. R.

Favourites:Add to Favourites

Free Content Baseline imaging after therapy for unprovoked venous thromboembolism: a randomized controlled comparison of baseline imaging for diagnosis of suspected recurrence
pp. 2406-2410(5)
Authors: HAMADAH, A.; ALWASAIDI, T.; LE GAL, G.; CARRIER, M.; WELLS, P. S.; SCARVELIS, D.; GONSALVES, C.; FORGIE, M.; KOVACS, M. J.; RODGER, M. A.

Favourites:Add to Favourites
Favourites:Add to Favourites

Free Content The impact of antiproteinuric therapy on the prothrombotic state in patients with overt proteinuria
pp. 2416-2423(8)
Authors: MAHMOODI, B. K.; MULDER, A. B.; WAANDERS, F.; SPRONK, H. M. H.; MULDER, R.; SLAGMAN, M. C. J.; VOGT, L.; NAVIS, G.; TEN CATE, H.; KLUIN‐NELEMANS, H. C.; LAVERMAN, G. D.

Favourites:Add to Favourites

Free Content Retention of thrombin inhibitory activity by recombinant serpins expressed as integral membrane proteins tethered to the surface of mammalian cells
pp. 2424-2435(12)
Authors: GIERCZAK, R. F.; SUTHERLAND, J. S.; BHAKTA, V.; TOLTL, L. J.; LIAW, P. C.; SHEFFIELD, W. P.

Favourites:Add to Favourites

Free Content Inhibition of staphylothrombin by dabigatran reduces Staphylococcus aureus virulence
pp. 2436-2446(11)
Authors: VANASSCHE, T.; VERHAEGEN, J.; PEETERMANS, W. E.; VAN RYN, J.; CHENG, A.; SCHNEEWIND, O.; HOYLAERTS, M. F.; VERHAMME, P.

Favourites:Add to Favourites

Free Content Induction of anti‐β2‐glycoprotein I autoantibodies in mice by protein H of Streptococcus pyogenes
pp. 2447-2456(10)
Authors: VAN OS, G. M. A.; MEIJERS, J. C. M.; AGAR, Ç.; SERON, M. V.; MARQUART, J. A.; ÅKESSON, P.; URBANUS, R. T.; DERKSEN, R. H. W. M.; HERWALD, H.; MÖRGELIN, M.; DE GROOT, P. G.

Favourites:Add to Favourites
Favourites:Add to Favourites

Free Content Validation of flow cytometric detection of platelet microparticles and liposomes by atomic force microscopy
pp. 2466-2476(11)
Authors: LEONG, H. S.; PODOR, T. J.; MANOCHA, B.; LEWIS, J. D.

Favourites:Add to Favourites

Free Content Expression and functionality of type I interferon receptor in the megakaryocytic lineage
pp. 2477-2485(9)
Authors: NEGROTTO, S.; DE GIUSTI, C. J.; LAPPONI, M. J.; ETULAIN, J.; RIVADENEYRA, L.; POZNER, R. G.; GOMEZ, R. M.; SCHATTNER, M.

Favourites:Add to Favourites

Free Content Heparin promotes soluble VEGF receptor expression in human placental villi to impair endothelial VEGF signaling
pp. 2486-2497(12)
Authors: DREWLO, S.; LEVYTSKA, K.; SOBEL, M.; BACZYK, D.; LYE, S. J.; KINGDOM, J. C. P.

Favourites:Add to Favourites

Free Content Laboratory testing for heparin‐induced thrombocytopenia: a conceptual framework and implications for diagnosis
pp. 2498-2500(3)
Authors: WARKENTIN, T. E.; GREINACHER, A.; GRUEL, Y.; ASTER, R. H.; CHONG, B. H.; on behalf of the scientific and standardization committee of the international society on thrombosis and haemostasis cr6

Favourites:Add to Favourites

Free Content Fondaparinux in acute heparin‐induced thrombocytopenia: a case series
pp. 2501-2503(3)
Authors: GOLDFARB, M. J.; BLOSTEIN, M. D.

Favourites:Add to Favourites
Favourites:Add to Favourites

Free Content In vivo von Willebrand factor size heterogeneity in spite of the clinical deficiency of ADAMTS‐13
pp. 2506-2508(3)
Authors: DE MEYER, S. F.; BUDDE, U.; DECKMYN, H.; VANHOORELBEKE, K.

Favourites:Add to Favourites

Free Content The presumed increased bleeding tendency in red‐haired individuals is not associated with von Willebrand factor antigen levels in older individuals
pp. 2509-2511(3)
Authors: LEEBEEK, F. W.G.; DEHGHAN, A.; KRUIP, M. J. H. A.; HOFMAN, A.; UITTERLINDEN, A. G.; DE WEE, E. M.; WITTEMAN, J. C. M.; DE MAAT, M. P. M.

Favourites:Add to Favourites

Free Content Procoagulant effect of vitamin K antagonists?
pp. 2511-2512(2)
Authors: AL DIERI, R.; Ten CATE‐HOEK, A.; BLOEMEN, S.; Ten CATE, H.; HEMKER, H. C.

Favourites:Add to Favourites

Free Content Altered fibrin clot properties in patients with retinal vein occlusion
pp. 2513-2515(3)
Authors: KARSKA‐BASTA, I.; KUBICKA‐TRZĄSKA, A.; ROMANOWSKA‐DIXON, B.; UNDAS, A.

Favourites:Add to Favourites

Free Content Join ISTH
pp. 2522-2522(1)

Favourites:Add to Favourites

Free Content Corrigendum
pp. 2523-2523(1)

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more